Cyan,Re ANP, 2.2 has shown to be resistance over the last few...

Cyan,

Re ANP, 2.2 has shown to be resistance over the last few weeks and I expect 2.3 to be the same. Mark Diamond presented at a US bio conference earlier in the week so could be some interest coming in from there. 3 drugs in the pipeline and shareholders are waiting on outcomes with potential partners on each one however this could be months away. I'd really like to see more volume. Looks like someone might want to push it higher though.